blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2406629

EP2406629 - IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  05.02.2021
Database last updated on 02.11.2024
Most recent event   Tooltip05.02.2021Revocation of patentpublished on 10.03.2021  [2021/10]
Applicant(s)For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine, CA 92612 / US
[N/P]
Former [2012/03]For all designated states
Allergan, Inc.
2525 Dupont Drive
Irvine, CA 92612 / US
Inventor(s)01 / WANG, Joanne
37 Bristlecone
Irvine CA 92620 / US
02 / ZHU, Hong
11408 Pacific Shores Way
San Diego CA 92130 / US
03 / HODGES, D., Diane
14351 Pinewood Road
Tustin CA 92780 / US
04 / FERNANDEZ-SALAS, Ester
1710 Rocky Road
Fullerton CA 92831 / US
 [2012/03]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[N/P]
Former [2013/38]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
Former [2012/03]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastraße 4
81925 München / DE
Application number, filing date10709360.112.03.2010
WO2010US27244
Priority number, dateUS20090160217P13.03.2009         Original published format: US 160217 P
[2012/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010105236
Date:16.09.2010
Language:EN
[2010/37]
Type: A1 Application with search report 
No.:EP2406629
Date:18.01.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 16.09.2010 takes the place of the publication of the European patent application.
[2012/03]
Type: B1 Patent specification 
No.:EP2406629
Date:18.09.2013
Language:EN
[2013/38]
Type: B9 Corrected patent specification 
No.:EP2406629
Date:26.03.2014
[2014/13]
Search report(s)International search report - published on:EP16.09.2010
ClassificationIPC:G01N33/50, C12Q1/37
[2012/03]
CPC:
C07K16/18 (EP,KR,US); G01N33/5014 (EP,KR,US); G01N33/573 (KR,US);
C12N9/52 (EP,KR,US); C12Q1/37 (EP,KR,US); C12Y304/24069 (EP,KR,US);
G01N33/5035 (EP,KR,US); G01N33/53 (KR,US); C07K2317/34 (EP,KR,US);
C07K2317/56 (KR,US); C07K2317/92 (EP,KR,US); G01N2333/33 (EP,KR,US);
G01N2333/47 (KR,US); G01N2333/952 (KR,US); G01N2333/96425 (KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/03]
Extension statesALNot yet paid
BANot yet paid
MENot yet paid
RSNot yet paid
TitleGerman:IMMUNBASIERTE TESTVERFAHREN FÜR ENDOPEPTIDASE-AKTIVITÄT MIT NEUEM ZIEL[2012/03]
English:IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS[2012/03]
French:DOSAGES IMMUNOLOGIQUES DE L'ACTIVITÉ DES ENDOPEPTIDASES RECIBLÉES[2012/03]
Entry into regional phase22.09.2011National basic fee paid 
22.09.2011Designation fee(s) paid 
22.09.2011Examination fee paid 
Examination procedure22.09.2011Examination requested  [2012/03]
28.02.2012Amendment by applicant (claims and/or description)
08.08.2012Despatch of a communication from the examining division (Time limit: M04)
18.12.2012Reply to a communication from the examining division
10.04.2013Communication of intention to grant the patent
05.08.2013Fee for grant paid
05.08.2013Fee for publishing/printing paid
Divisional application(s)EP12195253.5  / EP2568285
EP12196264.1  / EP2570809
EP17192861.7  / EP3281953
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.08.2012
Opposition(s)Opponent(s)01  18.06.2014  27.06.2014  ADMISSIBLE
Merz Pharma GmbH & Co. KGaA
Eckenheimer Landstrasse 100
60318 Frankfurt / DE
Opponent's representative
Altmann Stößel Dick Patentanwälte PartG mbB
Theodor-Heuss-Anlage 2
68165 Mannheim / DE
 [N/P]
Former [2014/32]
Opponent(s)01  18.06.2014  27.06.2014  ADMISSIBLE
Merz Pharma GmbH & Co. KGaA
Eckenheimer Landstrasse 100
60318 Frankfurt / DE
Opponent's representative
Herzog, Fiesser & Partner Patentanwälte PartG mbB
Patentanwälte
Dudenstrasse 46
68167 Mannheim / DE
14.08.2014Invitation to proprietor to file observations on the notice of opposition
12.12.2014Reply of patent proprietor to notice(s) of opposition
03.05.2016Date of oral proceedings
10.06.2016Despatch of minutes of oral proceedings
10.06.2016Despatch of communication that the patent will be revoked
17.09.2020Legal effect of revocation of patent [2021/10]
Appeal following opposition10.08.2016Appeal received No.  T1913/16
20.10.2016Statement of grounds filed
17.09.2020Result of appeal procedure: appeal of the proprietor was rejected
12.01.2021Despatch of the decision of the Board of Appeal
17.09.2020Date of oral proceedings
Fees paidRenewal fee
26.03.2012Renewal fee patent year 03
27.03.2013Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBG18.09.2013
CY18.09.2013
EE18.09.2013
FI18.09.2013
HR18.09.2013
LT18.09.2013
LV18.09.2013
MC18.09.2013
MK18.09.2013
MT18.09.2013
SI18.09.2013
SK18.09.2013
SM18.09.2013
IS18.01.2014
PT20.01.2014
LU12.03.2014
[2018/30]
Former [2016/28]BG18.09.2013
CY18.09.2013
EE18.09.2013
FI18.09.2013
HR18.09.2013
LT18.09.2013
LV18.09.2013
MC18.09.2013
MT18.09.2013
SI18.09.2013
SK18.09.2013
SM18.09.2013
IS18.01.2014
PT20.01.2014
LU12.03.2014
Former [2016/27]CY18.09.2013
EE18.09.2013
FI18.09.2013
HR18.09.2013
LT18.09.2013
LV18.09.2013
MC18.09.2013
MT18.09.2013
SI18.09.2013
SK18.09.2013
SM18.09.2013
IS18.01.2014
PT20.01.2014
LU12.03.2014
Former [2016/22]CY18.09.2013
EE18.09.2013
FI18.09.2013
HR18.09.2013
LT18.09.2013
LV18.09.2013
MT18.09.2013
SI18.09.2013
SK18.09.2013
SM18.09.2013
IS18.01.2014
PT20.01.2014
LU12.03.2014
Former [2016/12]CY18.09.2013
EE18.09.2013
FI18.09.2013
HR18.09.2013
LT18.09.2013
LV18.09.2013
MT18.09.2013
SI18.09.2013
SK18.09.2013
IS18.01.2014
PT20.01.2014
LU12.03.2014
Former [2014/48]CY18.09.2013
EE18.09.2013
FI18.09.2013
HR18.09.2013
LT18.09.2013
LV18.09.2013
SI18.09.2013
SK18.09.2013
IS18.01.2014
PT20.01.2014
LU12.03.2014
Former [2014/28]CY18.09.2013
EE18.09.2013
FI18.09.2013
HR18.09.2013
LT18.09.2013
LV18.09.2013
SI18.09.2013
SK18.09.2013
IS18.01.2014
PT20.01.2014
Former [2014/23]CY18.09.2013
EE18.09.2013
FI18.09.2013
HR18.09.2013
LT18.09.2013
LV18.09.2013
SI18.09.2013
SK18.09.2013
IS18.01.2014
Former [2014/18]CY18.09.2013
FI18.09.2013
HR18.09.2013
LT18.09.2013
LV18.09.2013
SI18.09.2013
Former [2014/12]CY07.08.2013
FI18.09.2013
HR18.09.2013
LT18.09.2013
LV18.09.2013
SI18.09.2013
Former [2014/10]CY07.08.2013
HR18.09.2013
LT18.09.2013
Former [2014/09]HR18.09.2013
LT18.09.2013
Former [2014/08]LT18.09.2013
Cited inInternational search[Y]WO9533850  (MICROBIOLOGICAL RES AUTHORITY [GB], et al);
 [Y]WO9633273  (SPEYWOOD LAB LTD [GB], et al);
 [Y]US2004219619  (FERNANDEZ-SALAS ESTER [US], et al);
by applicantUS4816567
 US5223409
 US5364791
 US5464758
 US5514578
 US5674980
 US5712089
 US5747641
 US5804604
 US5807715
 US5807746
 US5814618
 US5874534
 US5885793
 US5962255
 US5969108
 US5989545
 US6010884
 US6017732
 US6027930
 US6043339
 WO0034308
 US6080724
 US6140471
 US6172197
 WO0114570
 US6245531
 US6248558
 US6265563
 US6287817
 US6306993
 US2002037833
 US6432652
 US6432680
 US6461617
 US6495518
 US6495663
 US2003008813
 US2003180289
 US6632440
 US2004057958
 US6734167
 US6780843
 US2004209797
 US6841535
 US6843998
 WO2005023309
 US7034132
 US7034121
 WO2006059093
 WO2006059105
 US7132259
 US7244437
 US7282563
 US2007281320
 WO2008008805
 US7332567
 US2008057575
 US2008064092
 US2008138893
 US2008160561
 US7413742
 US7415338
 US7419676
 US2008219925
 US2008241881
 US2009005313
 US2009035822
 US2009048431
 US7514088
 US2009162341
 US20170611602
 US20060376696
 US20070776075
 US20070776043
 US20070776052
 US20070829475
 US20090403531
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.